Saxagliptin/Metformin – Nutzenbewertung gemäß § 35a SGB V [Saxagliptine/metformin (drug combination) - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
IQWiG
Record Status
This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Citation
IQWiG. Saxagliptin/Metformin – Nutzenbewertung gemäß § 35a SGB V. [Saxagliptine/metformin (drug combination) - Benefit assessment according to § 35a Social Code Book V (dossier assessment)] Cologne: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). IQWiG-Berichte 152. 2013